In 2018, Denmark launched a trial period allowing doctors to prescribe medical cannabis. The purpose was to give patients with chronic pain, who had tried other medications without improvement, access to cannabis.
The trial period was set to last until the end of 2025, but a broad majority in the parliament has already agreed to make the law permanent.
The new law will target patients with multiple sclerosis, spinal cord injuries, cancer, or chronic pain.
"Many experience less pain or nausea, which can significantly improve their quality of life," says Social Minister Sophie Løhde (V) in a press release.
"With this agreement, we ensure that patients who have not experienced a satisfactory effect from other medications will also be able to receive medical cannabis prescriptions under safe conditions in the future."
Several doctors in Denmark have criticized the temporary law and hesitated to prescribe cannabis, primarily directing criticism towards patients not receiving sufficient information about effects and side effects.
